Clinical Trials

44 enrolled

Locally Advanced Rectal Cancer

NCT05092412 2024-01-12

Low-dose Radiotherapy Combined With Durvalumab, Chemotherapy(EP) in the Treatment of ES-SCLC

Lung Neoplasms, Small Cell Lung Carcinoma

NCT02037048 2024-01-08

FOLFOX-6 Induction Chemotherapy Followed by Esophagectomy and Post-operative Chemoradiotherapy in Patients With Esophageal Adenocarcinoma

63 enrolled

Adenocarcinoma Of Esophagus, Esophageal Neoplasms

NCT06170697 2023-12-20

Advanced First-line Treatment of Short-term Postoperative Progression of Head and Neck Squamous Cell Carcinoma

46 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT03935256 2023-12-18

Adjuvant Sequential & Concurrent CarboTaxol + Radiotherapy for High Risk Endometrial Cancer

24 enrolled

Gynecologic

Neoplasms, Endometrial Neoplasms

NCT03620032 2023-12-06

DIPG

54 enrolled

CNS

Diffuse Intrinsic Pontine Glioma

NCT03341520 2023-11-30

GAZAI

89 enrolled

Lymphoid

Lymphoma, Follicular

NCT03729687 2023-11-30

LARCT-US

280 enrolled

Rectal Neoplasms

NCT05588219 2023-11-24

Tislelizumab Combined With Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer

Gynecologic

Uterine Cervical Neoplasms

NCT06120127 2023-11-07

IMPROVE

80 enrolled

Colorectal Neoplasms

NCT05010434 2023-09-21

Sintilimab and Bevacizumab Combined With Radiotherapy for Advanced Hepatocellular Carcinoma

46 enrolled

Carcinoma, Hepatocellular

NCT06047860 2023-09-21

A Clinical Study of Recombinant Human Vascular Endothelial Inhibitor in Combination With PRaG for Advanced Refractory Non-small Cell Lung Cancer

Tumor-Agnostic

Neoplasms

NCT05783076 2023-08-30

SBRT Plus vNKT for Pancreatic Cancer

29 enrolled

Pancreatic Neoplasms

NCT02679040 2023-07-03

HIST-RIC

101 enrolled

Breast

Breast Neoplasms

NCT05868317 2023-05-22

Induction Chemotherapy Followed by Short Course Radiotherapy in Rectal Cancer

70 enrolled

Rectal Neoplasms

NCT05790447 2023-03-30

Thymalfasin-based PRaG Mode for Advanced Refractory Solid Tumors

60 enrolled

Tumor-Agnostic

Neoplasms

NCT04030260 2023-03-23

Regorafenib and PD-1 Antibody in Combination With Radiotherapy for pMMR/MSS Metastatic Colorectal Cancer

28 enrolled

Colorectal Cancer Metastatic

NCT01590355 2023-03-08

ORATOR

68 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT05749042 2023-03-01

A Study of Concurrent Chemoradiotherapy Based of Cisplatin With or Without Sintilimab as First-line Therapy for Patients With Advanced Oral Cavity Squamous Cell Carcinoma

70 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT05708391 2023-02-01

Radiotherapy Combined With Realgar-Indigo Naturalis Formula (RIF) in the Treatment of Rhabdomyosarcoma(RMS) in Children

53 enrolled

Sarcoma

Rhabdomyosarcoma

NCT05659186 2022-12-21

PD-1 Inhibitor and Anlotinib Combined With Multimodal Radiotherapy in Recurrent or Metastatic Anaplastic Thyroid Cancer

20 enrolled

Thyroid Neoplasms

NCT05602415 2022-11-02

Anlotinib and Radiotherapy in Resectable Soft Tissue Sarcoma

41 enrolled

Sarcoma

NCT05603013 2022-11-02

Vinorelbine Metronomic Chemotherapy Combined With Hypofractionated Radiotherapy, PD-1/PD-L1 Sequential GM-CSF and IL-2 for Treatment of Advanced Refractory Non-small Cell Lung Cancer and Breast Cancer(PRaG 6.0)

45 enrolled

BreastThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT04575922 2022-09-08

Nivolumab+Ipilimumab+RT in MSS mCRC

32 enrolled

Metastatic Microsatellite Stable Colorectal Cancer

NCT02839343 2022-05-24

Combination Chemotherapy With or Without Hypofractionated Radiation Therapy Before Surgery in Treating Patients With Pancreatic Cancer

126 enrolled 12 charts

Pancreatic Adenocarcinoma

NCT05292417 2022-03-31

Radiotherapy in Combination With Sintilimab，GM-CSF and Fruquintinib in Patients With MSS mCRC

71 enrolled

Colorectal Neoplasms

NCT02499367 2022-03-22

TONIC

84 enrolled

Breast

Breast Neoplasms, Neoplasm Metastasis

NCT05212857 2022-03-16

Enhanced Systemic Combined With Local Treatment for Primary and Metastatic Lesions in Oligo-metastatic Prostate Cancer

160 enrolled

Genitourinary

Prostatic Neoplasms

NCT05160727 2021-12-20

Radiotherapy Combined With Tislelizumab and Irinotecan in MSS/pMMR Recurrence and Metastatic Colorectal Cancer

44 enrolled

Colorectal Neoplasms

NCT05149170 2021-12-08

Radiotherapy and Anti-PD-1 in Low-risk ES-ENKTCL

Lymphoid

Lymphoma, Extranodal NK-T-Cell

NCT05115500 2021-11-10

ADC Combined With Hypofractionated Radiotherapy, PD-1/PD-L1 Sequential GM-CSF and IL-2 for Treatment of HER-2 Positive Advanced Solid Tumors(PRaG3.0)

55 enrolled

Tumor-Agnostic

Carcinoma

NCT00558519 2021-08-18

Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

Other hematologic neoplasm

318 enrolled 9 charts

Leukemia

NCT04970693 2021-07-21

A Study of Furmonertinib Combined With Radiotherapy for Non-small Cell Lung Cancer With Oligoprogression

64 enrolled

Carcinoma, Non-Small-Cell Lung

NCT04884906 2021-05-13

Camrelizumab Combined With Radiotherapy and Chemotherapy for the Treatment of Recurrent or Metastatic Cervical Cancer

Gynecologic

Locally Advanced Cervical Cancer

NCT04828395 2021-05-11

F&C

65 enrolled

Carcinoma, Non-Small-Cell Lung

NCT00643318 2021-03-05

CyberKnife Radiosurgical Treatment of Inoperable Early Stage Non-Small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT04769076 2021-02-25

The Paclitaxel (Albumin-bound) Combined With Cisplatin, PD-1 Inhibitors and IMRT in the Treatment of Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

NCT03432780 2021-01-22

QRT-SOGUG

134 enrolled

Genitourinary

Prostatic Neoplasms

NCT04631757 2020-11-17

Conversion Therapy of Camrelizumab Plus Chemoradiotherapy in Participants With Initial Unresectable Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma

33 enrolled

Stomach Neoplasms

NCT04602013 2020-10-26

Sintilimab Injection Combined With Concurrent CCRT in Locally Advanced Esophageal Squamous Cell Carcinoma

53 enrolled

Esophageal Squamous Cell Carcinoma

NCT04569916 2020-09-30

Radiotherapy Combined With Irinotecan and Apatinib Followed by PD-1 Antibody and Apatinib for Advanced Solid Tumors

Other solid neoplasm

Solid Tumor

NCT01567202 2020-09-09

Study of DC Vaccination Against Glioblastoma

100 enrolled

CNS

Brain Neoplasms, Glioblastoma, Glioma, Neoplasms

NCT04513301 2020-08-14

Efficacy and Safety of Sintilimab With or Without Radiotherapy in Patients With Recurrent or IV NSCLC (EGFR -, ALK -) After Failure of Platinum-based Chemotherapy: A Randomized,Open Labled, Phase II Clinical Study

70 enrolled

Lung Neoplasms

NCT04333927 2020-06-23

ACCORD

92 enrolled

Biliary Tract Neoplasms, Gallbladder Neoplasms, Cholangiocarcinoma

NCT02887313 2020-05-04

FOTAC

200 enrolled

Rectal Neoplasms

NCT03022734 2020-01-13

Short Course Radiotherapy, Unresectable Rectal Cancer, Liver Metastasis

Neoplasm Metastasis, Rectal Neoplasms

NCT04193696 2020-01-09

RT+ Anti-PD-1 for Patients With Advanced HCC (RT+PD-1-HCC)

39 enrolled

Carcinoma, Hepatocellular

NCT04189094 2019-12-06

Chemoradiotherapy With or Without Sintilimab in Limited-stage SCLC

140 enrolled

Lung Neoplasms

NCT04157478 2019-11-12

Addition of Anlotinib Hydrochloride to the Stupp Regimen Versus the Stupp Regimen Alone for Newly Diagnosed Glioblastoma